MALINVERNO, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 1.545
EU - Europa 819
AS - Asia 203
SA - Sud America 3
Totale 2.570
Nazione #
US - Stati Uniti d'America 1.530
IT - Italia 213
DE - Germania 156
SE - Svezia 129
IE - Irlanda 108
CN - Cina 88
AT - Austria 69
RU - Federazione Russa 47
SG - Singapore 34
GB - Regno Unito 28
HK - Hong Kong 24
MY - Malesia 16
CA - Canada 15
BE - Belgio 13
DK - Danimarca 11
UA - Ucraina 11
IN - India 10
NL - Olanda 9
VN - Vietnam 9
FR - Francia 8
FI - Finlandia 7
TR - Turchia 6
MM - Myanmar 4
CZ - Repubblica Ceca 3
ID - Indonesia 3
TW - Taiwan 3
BR - Brasile 2
GR - Grecia 2
KR - Corea 2
NO - Norvegia 2
AR - Argentina 1
EE - Estonia 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
Totale 2.570
Città #
Ann Arbor 496
Chandler 167
Frankfurt am Main 144
Fairfield 131
Dublin 105
Wilmington 99
Woodbridge 82
Ashburn 69
Seattle 66
Vienna 66
Milan 56
New York 55
Houston 46
Cambridge 42
Shanghai 38
Princeton 36
Dearborn 29
Singapore 27
Hong Kong 24
Lawrence 18
Penang 16
Rome 15
Nanjing 13
Brussels 12
Altamura 11
Jacksonville 11
San Diego 10
Los Angeles 9
London 8
Toronto 7
Boardman 6
Buffalo 6
Helsinki 6
Fremont 5
Lissone 5
Pune 5
Appiano Gentile 4
Dong Ket 4
Kocaeli 4
Udine 4
Andover 3
Biassono 3
Bologna 3
Brno 3
Desio 3
Edmonton 3
Falls Church 3
Garbagnate Milanese 3
Genoa 3
Hebei 3
Jakarta 3
Jinan 3
Kunming 3
Modena 3
New Taipei 3
Shenyang 3
Vigevano 3
Athens 2
Bari 2
Beijing 2
Bergamo 2
Bonndorf 2
Carate Brianza 2
Castelnuovo Scrivia 2
Catania 2
Changsha 2
Dalmine 2
Dongguan 2
Franklin 2
Groningen 2
Guangzhou 2
Guiyang 2
Lucera 2
Meda 2
Monza 2
Mumbai 2
Nanchang 2
New Delhi 2
Ningbo 2
Norwalk 2
Oslo 2
Padova 2
Paris 2
Pavia 2
Rho 2
Sacramento 2
São Paulo 2
Tianjin 2
Triggiano 2
Wuhan 2
Amsterdam 1
Ankara 1
Arnsberg 1
Avigliana 1
Belsize Park 1
Bresso 1
Busto Arsizio 1
Chapel Hill 1
Chicago 1
Chuo 1
Totale 2.084
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 406
A worldwide cross-ethnic study of quality of life in patients with PBC: Attitude or latitude? 290
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 185
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 174
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 173
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 171
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach 170
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis 167
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 158
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 152
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 130
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 93
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 79
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 76
Comprehensive review of autoantibodies in patients with hyper-IgM syndrome 72
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 58
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 57
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 52
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 49
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 15
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 10
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 6
Totale 2.743
Categoria #
all - tutte 9.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.528


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020368 0 33 18 41 45 40 48 33 39 32 30 9
2020/2021612 12 12 102 37 37 97 61 66 43 40 60 45
2021/2022408 44 45 57 39 31 27 10 33 19 17 29 57
2022/2023653 60 196 63 70 73 56 25 31 42 9 24 4
2023/2024412 16 12 9 37 38 110 71 13 20 30 12 44
2024/202560 45 15 0 0 0 0 0 0 0 0 0 0
Totale 2.743